Stanley Stern - 04 Dec 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Director
Signature: /s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol: EKSO
Transactions as of: 04 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Dec 2022, 18:04:19 UTC
Previous filing: 17 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Award	$0	+87,787	+111%	$0.000000	167,008	04 Dec 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs fully vested on December 4, 2022 and were delivered to the Reporting Person upon settlement.
F2	Includes 51,721 unvested RSUs.

Content

The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs fully vested on December 4, 2022 and were delivered to the Reporting Person upon settlement.

Includes 51,721 unvested RSUs.